RxDoctor Payments Data

Ahlam Wolf, PA

Surgical · Chesterton, INNPI 1477863264

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.6% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Johnson & Johnson at 31.8% of the total. 2025 is the largest year on record at $503, 9.3 times the $54 reported in 2022.

$654in general payments, 2019–2025

Across 22 payments — averaging $29.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$208
  • Stryker$154
  • Amgen$105
  • AbbVie$55
  • E.r. Squibb & Sons, L.L.C.$33
  • UCB, Inc.$29
  • plus $70 from 4 others

What the payments were for

  • Food & beverage$59992%
  • Education$558%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson(2 entities)6$208
Stryker6$154
Amgen2$105
AbbVie2$55
E.r. Squibb & Sons, L.L.C.1$33
UCB, Inc.1$29
Genentech USA, Inc.1$21
Orthofix Medical, Inc.1$17
Lightbody Medical Technologies Inc1$17
Kowa Pharmaceuticals America, Inc.1$14

How this compares

$654 in reported general payments places this provider in the 60th percentile of 130 surgical providers in Indiana.

See all surgical providers in Indiana

Medicare billing

Part B allowed, 2024
$18,357
Medicare patients
123
Services billed
774

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone21$92

Paid to pharmacies, not to this prescriber.

Other surgical in Chesterton

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →